FLT3LG and neoplasm: To evaluate the mechanisms regulating DC cross-presentation by tumor-derived factors (TDF), we generated DCs in vitro from bone marrow (BM) progenitors using two methods allowing for the generation of fully differentiated DCs: 5-day culture with GM-CSF or 6-day culture with FLT3L.